← Leaderboards
Igor Kogut
University Of Colorado Denver
$2,346,523
Attributed
$2,346,523
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $476.5K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,346,523 · 1
By mechanism
R01$2,346,523 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Yiqun G Shellman$2,394,048
- Mary Cm Weiser-Evans$14,403,734
- Ganna Bilousova$780,301
- Tamara G Terzian$658,360
- Heide L Ford$14,422,349
Others in their field
Other Emerging Leaders on “Drug Testing”
- Leonard Freedman · Leidos Biomedical Research, Inc.$242,494,514
- Lynn Briscoe · Leidos Biomedical Research, Inc.$98,117,521
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$54,459,089
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Drug TestingDna DamageComplexConnective Tissue DiseasesAdultAutologous TransplantationClonal ExpansionBirthBurn InjuryAgedCell DivisionCell LineCell PhysiologyCell ProliferationAdult Stem CellCellsCell TransplantationCell TypeCellular EngineeringCharacteristicsCell AgingChronic WoundClinically RelevantEnzyme Activity
Grant awards (5)
Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules$462,227
R01 · FY2025 · AR · contact PI
Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules$462,227
R01 · FY2024 · AR · contact PI
Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules$476,524
R01 · FY2023 · AR · contact PI
Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules$471,758
R01 · FY2022 · AR · contact PI
Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules$473,787
R01 · FY2021 · AR · contact PI